Identification of distinct blood-based biomarkers in early stage of Parkinson’s disease
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Identification of distinct blood-based biomarkers in early stage of Parkinson’s disease
Authors
Keywords
-
Journal
NEUROLOGICAL SCIENCES
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-12-11
DOI
10.1007/s10072-019-04165-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Plasma alpha-synuclein levels in patients with Parkinson’s disease: a systematic review and meta-analysis
- (2019) Anastasia Bougea et al. NEUROLOGICAL SCIENCES
- The clinical symptoms of Parkinson's disease
- (2016) Sigurlaug Sveinbjornsdottir JOURNAL OF NEUROCHEMISTRY
- Oxidative stress, mitochondrial dysfunction and neurodegenerative diseases; a mechanistic insight
- (2015) Aashiq Hussain Bhat et al. BIOMEDICINE & PHARMACOTHERAPY
- Potential utility of autoantibodies as blood-based biomarkers for early detection and diagnosis of Parkinson’s disease
- (2015) Cassandra A. DeMarshall et al. IMMUNOLOGY LETTERS
- Parkinson's disease
- (2015) Lorraine V Kalia et al. LANCET
- Biomarkers of Parkinson’s disease: Present and future
- (2015) Diane B. Miller et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Assessment of Protective Role of Multifunctional Dopamine Agonist D-512 Against Oxidative Stress Produced by Depletion of Glutathione in PC12 Cells: Implication in Neuroprotective Therapy for Parkinson’s Disease
- (2015) Chandrashekhar Voshavar et al. NEUROTOXICITY RESEARCH
- Mitochondrial dysfunction and mitophagy in Parkinson's: from familial to sporadic disease
- (2015) Brent J. Ryan et al. TRENDS IN BIOCHEMICAL SCIENCES
- Deregulation of protein translation control, a potential game-changing hypothesis for Parkinson's disease pathogenesis
- (2015) Jean-Marc Taymans et al. TRENDS IN MOLECULAR MEDICINE
- Estimating the direct and indirect costs associated with Parkinson’s disease
- (2015) Carmen Rodríguez-Blázquez et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Immunotherapy in Parkinson’s Disease: Micromanaging Alpha-Synuclein Aggregation
- (2015) Sonia George et al. Journal of Parkinsons Disease
- Blood Biomarkers Associated with Cognitive Decline in Early Stage and Drug-Naive Parkinson’s Disease Patients
- (2015) Jose A. Santiago et al. PLoS One
- Low clinical diagnostic accuracy of early vs advanced Parkinson disease: Clinicopathologic study
- (2014) C. H. Adler et al. NEUROLOGY
- Gene Ontology Consortium: going forward
- (2014) NUCLEIC ACIDS RESEARCH
- Inhibition of the Fe(III)-Catalyzed Dopamine Oxidation by ATP and Its Relevance to Oxidative Stress in Parkinson’s Disease
- (2013) Dianlu Jiang et al. ACS Chemical Neuroscience
- Therapeutic prospects for Parkinson disease
- (2013) C. Warren Olanow et al. ANNALS OF NEUROLOGY
- Deep brain stimulation modulates nonsense-mediated RNA decay in Parkinson’s patients leukocytes
- (2013) Lilach Soreq et al. BMC GENOMICS
- The Role of Inflammatory and Oxidative Stress Mechanisms in the Pathogenesis of Parkinson’s Disease: Focus on Astrocytes
- (2013) Rituraj Niranjan MOLECULAR NEUROBIOLOGY
- Pathogenesis-Targeted, Disease-Modifying Therapies in Parkinson Disease
- (2013) Amaal AlDakheel et al. Neurotherapeutics
- Signaling Pathways Involved in 1-Octen-3-ol-Mediated Neurotoxicity in Drosophila melanogaster: Implication in Parkinson’s Disease
- (2013) Arati A. Inamdar et al. NEUROTOXICITY RESEARCH
- Statistical analysis and mapping of the unified Parkinson’s Disease rating scale to Hoehn and Yahr staging
- (2012) Athanasios Tsanas et al. PARKINSONISM & RELATED DISORDERS
- DJ-1 isoforms in whole blood as potential biomarkers of Parkinson disease
- (2012) Xiangmin Lin et al. Scientific Reports
- Mitochondria and Programmed Cell Death in Parkinson's Disease: Apoptosis and Beyond
- (2011) Celine Perier et al. ANTIOXIDANTS & REDOX SIGNALING
- Parkinsonism: Onset, progression, and mortality
- (2011) M. Hoehn et al. NEUROLOGY
- ATP-Binding Cassette Transporters and Their Roles in Protecting the Brain
- (2011) Ayman ElAli et al. NEUROSCIENTIST
- Progression of Parkinson's disease as evaluated by Hoehn and Yahr stage transition times
- (2010) Ying Jiao Zhao et al. MOVEMENT DISORDERS
- Clinical Criteria for the Diagnosis of Parkinson’s Disease
- (2010) Heinz Reichmann Neurodegenerative Diseases
- Selegiline use is associated with a slower progression in early Parkinson’s disease as evaluated by Hoehn and Yahr Stage transition times
- (2010) Y.J. Zhao et al. PARKINSONISM & RELATED DISORDERS
- Comparative responsiveness of Parkinson's disease scales to change over time
- (2009) Anette Schrag et al. MOVEMENT DISORDERS
- KEGG for representation and analysis of molecular networks involving diseases and drugs
- (2009) Minoru Kanehisa et al. NUCLEIC ACIDS RESEARCH
- Limbic and Frontal Cortical Degeneration Is Associated with Psychiatric Symptoms in PINK1 Mutation Carriers
- (2008) Kathrin Reetz et al. BIOLOGICAL PSYCHIATRY
- Biochemical aspects of the neuroprotective mechanism of PTEN-induced kinase-1 (PINK1)
- (2008) Ryan D. Mills et al. JOURNAL OF NEUROCHEMISTRY
- The history of dopamine and levodopa in the treatment of Parkinson's disease
- (2008) Stanley Fahn MOVEMENT DISORDERS
- LRRK2 is a component of granular alpha-synuclein pathology in the brainstem of Parkinson's disease
- (2007) J. Alegre-Abarrategui et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- A formula for the conversion of UPDRS-III scores to Hoehn and Yahr stage
- (2007) Blake K. Scanlon et al. PARKINSONISM & RELATED DISORDERS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started